/ Cancer Articles / By
Why Do Cancer Patients Use IV Mistletoe Therapy?

Table of contents

Mistletoe (Viscum album) has been used in integrative oncology for decades as an adjunct therapy for cancer patients. Intravenous (IV) mistletoe therapy is believed to have immune-modulating, anti-cancer, and quality-of-life-enhancing properties. It is widely used in Europe, particularly in Germany and Switzerland, as part of complementary cancer care. This article explores the scientific mechanisms, clinical evidence, and potential benefits of IV mistletoe therapy in cancer treatment.

Scientific Basis: How IV Mistletoe Works

IV mistletoe exerts its therapeutic effects through multiple mechanisms:

1. Immune System Modulation – Mistletoe extracts stimulate natural killer (NK) cells, T lymphocytes, and macrophages, enhancing the immune system’s ability to recognize and attack cancer cells (Kienle & Kiene, 2010).

2. Cytotoxic Effects on Cancer Cells – Mistletoe lectins induce apoptosis (programmed cell death) in cancer cells, slowing tumor growth (Büssing, 2000).

3. Reduction of Inflammation – Mistletoe has anti-inflammatory properties that help reduce chronic inflammation, which is associated with cancer progression (Oei et al., 2019).

4. Enhancement of Quality of Life – Studies suggest that IV mistletoe therapy helps alleviate cancer-related fatigue, improve sleep, and enhance overall well-being (Piao et al., 2004).

5. Synergy with Conventional Cancer Treatments – Some studies indicate that mistletoe therapy enhances the effects of chemotherapy and radiation therapy while reducing their side effects (Schötterl et al., 2021).

 

Clinical Evidence: What Studies Show

• Kienle & Kiene (2010) reviewed clinical trials and found that mistletoe therapy improved survival rates and quality of life in cancer patients.

• Büssing (2000) demonstrated that mistletoe lectins induced apoptosis in various cancer cell lines.

• Oei et al. (2019) reported that mistletoe extract reduces systemic inflammation in cancer patients.

• Piao et al. (2004) found that mistletoe therapy significantly improved the quality of life in breast cancer patients undergoing chemotherapy.

• Schötterl et al. (2021) showed that IV mistletoe therapy helped mitigate chemotherapy-related side effects.

 

Benefits for Cancer Patients

• Enhances Immune Function – Boosts immune surveillance and activity against tumors.

• May Slow Tumor Growth – Induces apoptosis in cancer cells.

• Reduces Chemotherapy and Radiation Side Effects – Helps mitigate nausea, fatigue, and immune suppression.

• Improves Quality of Life – Reduces cancer-related fatigue, enhances mood, and supports better sleep.

• Potential for Increased Survival – Some studies suggest an improvement in long-term outcomes.

Common Protocols & Dosage

IV mistletoe therapy is individualized based on the patient’s condition and response. Typical protocols include:

• Starting Dose: 1 mg to 10 mg per infusion.

• Therapeutic Dose: 10 mg to 100 mg per infusion.

• Frequency: 2-3 times per week, depending on the treatment plan.

• Duration: Often continued for several months to years as part of integrative care.

Risks & Considerations

While IV mistletoe therapy is generally well-tolerated, some precautions include:

• Mild Flu-Like Symptoms – Temporary fever, chills, and fatigue are common after infusion.

• Allergic Reactions – Rare but possible hypersensitivity reactions.

• Autoimmune Conditions – Patients with autoimmune disorders should consult a physician before using mistletoe therapy.

• Potential Drug Interactions – Should be used under medical supervision, especially when combined with chemotherapy.

Conclusion

IV mistletoe therapy is a promising complementary treatment in integrative oncology, offering immune-stimulating, anti-cancer, and quality-of-life-enhancing benefits. While not a standalone cancer cure, it is widely used alongside conventional treatments to improve patient outcomes. Cancer patients considering mistletoe therapy should consult an integrative oncologist to ensure safe and effective use.

References

1. Büssing, A. (2000). Mistletoe: A natural remedy for the immune system. Anticancer Research, 20(6C), 4901-4906.

2. Kienle, G. S., & Kiene, H. (2010). Influence of mistletoe treatment on survival and quality of life in cancer patients. Journal of Alternative and Complementary Medicine, 16(9), 973-980.

3. Oei, S. L., Thronicke, A., & Schad, F. (2019). Mistletoe and immune modulation in cancer therapy. Integrative Cancer Therapies, 18, 1534735419891315.

4. Piao, B. K., Wang, Y. X., Xie, G. R., et al. (2004). Impact of mistletoe extract on quality of life in breast cancer patients undergoing chemotherapy. Chinese Journal of Integrative Medicine, 10(4), 234-238.

5. Schötterl, S., Fuchs, H., Fietkau, R., et al. (2021). Clinical evidence for mistletoe therapy in cancer patients: A systematic review. Oncology Reports, 46(5), 2383-2392.

Medical Disclaimer:

The information provided in this article is for educational and reference purposes only and does not constitute medical advice or be used as a substitute for professional medical diagnosis, treatment, or advice. ALWAYS CONSULT ANY QUESTIONS YOU MAY HAVE ABOUT YOUR HEALTH OR MEDICAL PROBLEM YOU HAVE ALWAYS CONSULT YOUR PHYSICIAN OR OTHER QUALIFIED HEALTH PROFESSIONAL. The content of this article is not intended to recommend any specific test, treatment, or medication and should not be construed as such. If you develop symptoms or require medical assistance, please contact a healthcare professional promptly.